Sinopharm Group Co Ltd
HKEX:1099
EV/IC
Enterprise Value to IC
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
Market Cap | EV/IC | ||||
---|---|---|---|---|---|
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
68.5B HKD | 0.2 | ||
US |
Mckesson Corp
NYSE:MCK
|
73.4B USD | 4.7 | ||
US |
Cencora Inc
NYSE:COR
|
44.3B USD | 3 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 2.4 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24.2B USD | 2.5 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.6B USD | 1.3 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 4.7 | |
IT |
Amplifon SpA
MIL:AMP
|
7.8B EUR | 2.8 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
58.2B CNY | 2.3 | ||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
52.6B CNY | 0.6 | ||
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 1.4 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.